Lupin Profit & Loss Annual

Trade

BSE: 500257 | NSE: LUPIN | ISIN: INE326A01037 | Sector: Biotechnology & Drugs

889.05 +8.25 (0.94%)Updated : 28 Jun 2023

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	20,010.82	16,641.66	16,405.48	15,162.96
Total Revenue	20,010.82	16,641.66	16,405.48	15,162.96
Costof Revenue Total	6,643.47	7,702.99	7,486.11	5,905.20
Gross Profit	13,367.35	8,938.67	8,919.37	9,257.76
Selling/ General/ Admin Expenses Total	3,494.57	7,019.52	6,625.43	6,556.71
Depreciation/ Amortization	1,196.81	841.31	818.50	887.41
Other Operating Expenses Total	6,072.77	156.81	150.84	122.82
Total Operating Expense	17,407.62	15,760.01	17,799.47	13,472.14
Operating Income	2,603.20	881.65	-1,393.99	1,690.82
Interest Inc( Exp) Net- Non- Op Total	-3,011.00	-1,312.80	-93.40	-328.80
Other Net	120.17	-54.86	31.12	17.58
Net Income Before Taxes	2,422.27	716.49	-1,372.21	1,676.45
Provisionfor Income Taxes	486.70	268.80	137.15	448.52
Net Income After Taxes	1,935.57	447.69	-1,509.36	1,227.93
Minority Interest	-21.09	-17.61	-18.68	-11.40
Net Income Before Extra Items	1,914.48	430.08	-1,528.04	1,216.53
Net Income	1,914.48	430.08	-1,528.04	1,216.53
Income Availableto Com Excl Extra Ord	1,914.48	430.08	-1,528.04	1,216.53
Income Availableto Com Incl Extra Ord	1,914.48	430.08	-1,528.04	1,216.53
Diluted Net Income	1,914.48	430.08	-1,528.04	1,216.53
Diluted Weighted Average Shares	45.72	45.69	45.40	45.52
Diluted EPS Excluding Extra Ord Items	41.87	9.41	-33.65	26.72
DPS- Common Stock Primary Issue	8.00	4.00	4.00	6.50
Diluted Normalized EPS	41.87	9.66	5.26	26.71
Unusual Expense( Income)	-	39.38	2,718.59	0.00
Gain( Loss)on Saleof Assets	-	209.80	0.00	9.30
Total Extraordinary Items	-	-	-	0.00